EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Intermittent escitalopram treatment and reactive aggression in women with premenstrual irritability and anger: A crossover study

Maria Gröndal, Jakob Näslund, Christin Englund, Timothy J Luke, Karl Ask, Elias Eriksson, Stefan Winblad

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2024.10.020 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Maria Gröndal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Gothenburg, Sweden. Electronic address: maria.grondal@psy.gu.se. Hauptthemen laut MEDLINE: Anger, Cross-Over Studies, Aggression, Irritable Mood. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Västra Götalandsregionen, Brain Foundation, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Selective serotonin reuptake inhibitors (SSRI) are the primary treatment for premenstrual mood symptoms and particularly effective in reducing reactive aggression in the forms of irritability and anger. The present study examined whether behavioral responses in laboratory measures of reactive aggression are influenced by medication with the SSRI escitalopram in women reporting high levels of premenstrual irritability/anger. METHODS: Participants (N = 34) rated the cardinal mood symptoms of premenstrual dysphoric disorder over three menstrual cycles. During the second and third cycles, participants received escitalopram (20 mg) or placebo in a single-blind, cross-over design. In the luteal phase of the intervention cycles, participants completed two aggression tasks: The Anger-Infused Ultimatum Game (AI-UG) and the Point Subtraction Aggression Paradigm (PSAP). Additionally, they rated expression and control of anger using the State-Trait Anger Expression Inventory-2 (STAXI-2) once in the luteal phase and once in the follicular phase. RESULTS: While irritability/anger was reduced in the treatment (vs. placebo) cycle, no effect of escitalopram was detected in the PSAP. Escitalopram decreased reactive aggressive behavior in the AI-UG but only for a subset of participants who experienced a sharp premenstrual rise in outwardly expressed anger and/or did not experience a premenstrual rise in inwardly expressed anger. LIMITATIONS: The participants' symptoms were based on the severity of only premenstrual irritability/anger, limiting the generalizability to the broader group of PMDD patients. CONCLUSION: The results suggest that the behavioral consequences of severe premenstrual irritability/anger are not easily captured by traditional measures of reactive aggression and underline the importance of considering individual differences in symptom expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngerCross-Over StudiesAggressionIrritable MoodSelective Serotonin Reuptake InhibitorsEscitalopramHumansFemaleAdultSingle-Blind MethodYoung AdultCitalopramPremenstrual SyndromePremenstrual Dysphoric DisorderLuteal PhaseFollicular Phase

Stichwörter der Autor:innen

EscitalopramPMDDPoint Subtraction Aggression ParadigmPremenstrual irritabilitySelective serotonin uptake inhibitorsThe Anger-Infused Ultimatum Game

Substanzen

Selective Serotonin Reuptake InhibitorsEscitalopramCitalopram

Autor:innen und Institutionen

  • Department of Psychology, University of Gothenburg, Sweden. Electronic address: maria.grondal@psy.gu.se.
  • Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Sweden.
  • Department of Psychology, University of Gothenburg, Sweden.

Förderung

  • Västra Götalandsregionen
  • Brain Foundation
  • Swedish Research Council

Zitieren

APA

Gröndal, M., Näslund, J., Englund, C., Luke, T. J., Ask, K., Eriksson, E., & Winblad, S. (2025). Intermittent escitalopram treatment and reactive aggression in women with premenstrual irritability and anger: A crossover study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.10.020

Vancouver

Gröndal M, Näslund J, Englund C, Luke TJ, Ask K, Eriksson E, et al. Intermittent escitalopram treatment and reactive aggression in women with premenstrual irritability and anger: A crossover study. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.10.020

BibTeX
@article{Grndal2025,
  author = {Gröndal, Maria and Näslund, Jakob and Englund, Christin and Luke, Timothy J and Ask, Karl and Eriksson, Elias and Winblad, Stefan},
  title = {Intermittent escitalopram treatment and reactive aggression in women with premenstrual irritability and anger: A crossover study},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2024.10.020}
}
Kostenlos starten →